The report will be delivered in 2-3 business days.

Generic Pharmaceuticals Global Market Report 2021 - By Therapy (CNS, Cardiovascular, Dermatology, Genitourinary/Harmonal, Respiratory, Rheumatology, Diabetes, Oncology), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Type (Biosimilar, Simple Generic, Super Generic), By Drug Delivery (Oral, Inectables, Dermal/Topical, Inhaler), COVID-19 Growth And Change

Starting Price : $5000.00 | Pages : 175 | Published : March 2021 | SKU CODE : 7106 | Format :


The generic pharmaceuticals market consists of sales of generic pharmaceuticals. A generic medicine is a medication designed to be identical as branded drugs marketed by private companies in dosage form, strength, safety, route of administration, performance characteristics, quality, and intended use. Generic drugs work in the same way as branded drugs in terms of clinical benefits. Generic drugs are manufactured after the expiration of the exclusive rights or patent of the branded drugs. For example, some of the generic drugs in the generic pharmaceuticals market include metformin, metoprolol, acarbose, acebutolol, aztreonam and many more.

The generic pharmaceuticals market covered in this report is segmented by therapy into CNS, cardiovascular, dermatology, genitourinary/harmonal, respiratory, rheumatology, diabetes, oncology. It is also segmented by distribution channel into hospital pharmacies, retail pharmacies, online pharmacies; by type into biosimilar, simple generic, super generic; by drug delivery into oral, inectables, dermal/topical, inhaler.

The global generic pharmaceuticals market is expected to grow from $233.66 billion in 2020 to $245.6 billion in 2021 at a compound annual growth rate (CAGR) of 5.1%. The growth is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The generic pharmaceuticals market is expected to reach $331.54 billion in 2025 at a CAGR of 7.8%.

The rising incidence of chronic diseases is one of the major drivers of the generic pharmaceuticals market. As more individuals are diagnosed with chronic diseases, they look for more medicines for the treatment. Branded drugs come at a premium price, while generic drugs are available at a lower cost having the same chemical composition of branded drugs. The low cost and same chemical composition and strength of generic drugs make a patient buy generic drugs instead of branded drugs. If it is a chronic disease, the treatment goes for a longer period of time and hence, the sales of generic drugs also increase. For instance, according to the WHO (World Health Organization), over the next 10 years, the deaths due to chronic disease is projected to increase by 17%. Also, in 2020, almost 3-quarters of all deaths in the world is due to chronic diseases.

The lack of awareness about generic drugs is one of the restraints on the generic pharmaceuticals market. The high marketing and advertisement of branded drugs overshadow the availability of generic drugs which are substitute for expensive branded drugs. Thus, consumers opt for branded drugs despite the fact that the generic drugs carry the same chemical formulation as their counter branded drugs. According to an article published on CVS HEALTH, many doctors and pharmacists preferred to offer branded drugs to their patients over generic drugs. This prevents the patients to go for generic drugs as they develop a preconceived notion of generic drugs not being at par with branded drugs. For example, according to a research conducted by Sahana K Hebbar, on International Journal of Basic & Clinical Pharmacology, out of 100 patients and 50 non-medical staff, 95% of the patients and 60% of the non-medical staff didn't know about generic drugs. Thus, lack of awareness about the availability of generic drugs hamper the generic pharmaceuticals market.

3D printing technology has the ability to transform the manufacturing of drugs in the generic pharmaceuticals market. 3D printed pharmaceuticals help in improve R&D productivity and deliver new benefits to patients. 3D printing allows the manufacturer to produce drugs with customized size, shape, and texture which is not possible in traditional manufacturing of generic drugs. 3D printing can help the manufacturer to make generic drugs that have different release dates, appearances and taste. For example, GlaxoSmithKline (GSK) completed a study where ultraviolet (UV) and 3D printing were used to manufacture tablets to treat Parkinson's disease. Martin Wallace, director of GSK Technology, said that GSK is investing in 3D printing advantages to manufacture pills and tablets. Also, Aprecia pharmaceutical company launched 'ZipDose' technology which manufactures 3D printed drugs.

The drug manufacturers must comply with the CGMP (Current Good Manufacturing Practice) regulations that come under the US Food and Drug Administration (FDA) which includes generic pharmaceuticals. The CGMP regulations require manufacturers to maintain a minimum quality standard for the methods, controls, and facilities used in manufacturing, packaging, and processing of drug product. The part- 99 of chapter 1 under title 21-Food And Drugs of CFR (Code of Federal Regulations) contains subparts from A to H. The whole part-99 describes the guidelines that need to be followed by drug manufacturers regarding the dissemination of information on human drugs, including biologics, and devices. The guidelines concern with the safety, effectiveness, or benefit of use that is not included in the approved labelling for a drug or device approved by the Food and Drug Administration for marketing. The guidelines regulate the information regarding the drugs that should be delivered to the health care practitioner, pharmacy benefit manager, health insurance issuer, group health plan, or federal or state government agency.

In January 2020, ANI Pharmaceuticals, Inc., a USA based integrated specialty pharmaceutical company focused on developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals acquired Commercial and Pipeline Generic Products from Amerigen Pharmaceuticals, Ltd. for $52.5M in cash. This acquisition substantially increases ANI Pharmaceuticals, Inc. commercial portfolio and late stage generic pipeline. Amerigen Pharmaceuticals, a USA based company focused on development, manufacture and sale of high quality generic pharmaceutical products.

Major players in the generic pharmaceuticals market are Teva Pharmaceuticals, Mylan NV, Sandoz International GmbH, Hospira (Pfizer Inc.) and Sun Pharmaceutical.

The regions covered in the generic pharmaceuticals market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the generic pharmaceuticals market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The global generic pharmaceuticals market is segmented -

1) By Therapy: CNS, Cardiovascular, Dermatology, Genitourinary/Harmonal, Respiratory, Rheumatology, Diabetes, Oncology

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

3) By Type: Biosimilar, Simple Generic, Super Generic

4) By Drug Delivery: Oral, Inectables, Dermal/Topical, Inhaler

    Table Of Contents

    1. Executive Summary

    2. Generic Pharmaceuticals Market Characteristics

    3. Generic Pharmaceuticals Market Trends And Strategies

    4. Impact Of COVID-19 On Generic Pharmaceuticals

    5. Generic Pharmaceuticals Market Size And Growth

    5.1. Global Generic Pharmaceuticals Historic Market, 2015-2020, $ Billion

    5.1.1. Drivers Of The Market

    5.1.2. Restraints On The Market

    5.2. Global Generic Pharmaceuticals Forecast Market, 2020-2025F, 2030F, $ Billion

    5.2.1. Drivers Of The Market

    5.2.2. Restraints On the Market

    6. Generic Pharmaceuticals Market Segmentation

    6.1. Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    CNS

    Cardiovascular

    Dermatology

    Genitourinary/Harmonal

    Respiratory

    Rheumatology

    Diabetes

    Oncology

    6.2. Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Hospital Pharmacies

    Retail Pharmacies

    Online Pharmacies

    6.3. Global Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Biosimilar

    Simple Generic

    Super Generic

    6.4. Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    Oral

    Inectables

    Dermal/Topical

    Inhaler

    7. Generic Pharmaceuticals Market Regional And Country Analysis

    7.1. Global Generic Pharmaceuticals Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    7.2. Global Generic Pharmaceuticals Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8. Asia-Pacific Generic Pharmaceuticals Market

    8.1. Asia-Pacific Generic Pharmaceuticals Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    8.3. Asia-Pacific Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    9. China Generic Pharmaceuticals Market

    9.1. China Generic Pharmaceuticals Market Overview

    9.2. China Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    9.3. China Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F,$ Billion

    10. India Generic Pharmaceuticals Market

    10.1. India Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    10.2. India Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11. Japan Generic Pharmaceuticals Market

    11.1. Japan Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    11.2. Japan Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12. Australia Generic Pharmaceuticals Market

    12.1. Australia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    12.2. Australia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13. Indonesia Generic Pharmaceuticals Market

    13.1. Indonesia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    13.2. Indonesia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14. South Korea Generic Pharmaceuticals Market

    14.1. South Korea Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    14.2. South Korea Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15. Western Europe Generic Pharmaceuticals Market

    15.1. Western Europe Generic Pharmaceuticals Market Overview

    15.2. Western Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    15.3. Western Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16. UK Generic Pharmaceuticals Market

    16.1. UK Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    16.2. UK Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17. Germany Generic Pharmaceuticals Market

    17.1. Germany Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    17.2. Germany Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18. France Generic Pharmaceuticals Market

    18.4. France Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    18.5. France Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19. Eastern Europe Generic Pharmaceuticals Market

    19.1. Eastern Europe Generic Pharmaceuticals Market Overview

    19.2. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    19.3. Eastern Europe Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20. Russia Generic Pharmaceuticals Market

    20.1. Russia Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    20.2. Russia Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21. North America Generic Pharmaceuticals Market

    21.1. North America Generic Pharmaceuticals Market Overview

    21.2. North America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    21.3. North America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22. USA Generic Pharmaceuticals Market

    22.1. USA Generic Pharmaceuticals Market Overview

    22.2. USA Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    22.3. USA Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23. South America Generic Pharmaceuticals Market

    23.1. South America Generic Pharmaceuticals Market Overview

    23.2. South America Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    23.3. South America Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24. Brazil Generic Pharmaceuticals Market

    24.1. Brazil Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    24.2. Brazil Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25. Middle East Generic Pharmaceuticals Market

    25.1. Middle East Generic Pharmaceuticals Market Overview

    25.2. Middle East Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    25.3. Middle East Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26. Africa Generic Pharmaceuticals Market

    26.1. Africa Generic Pharmaceuticals Market Overview

    26.2. Africa Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    26.3. Africa Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion

    27. Generic Pharmaceuticals Market Competitive Landscape And Company Profiles

    27.1. Generic Pharmaceuticals Market Competitive Landscape

    27.2. Generic Pharmaceuticals Market Company Profiles

    27.2.1. Teva Pharmaceuticals

    27.2.1.1. Overview

    27.2.1.2. Products and Services

    27.2.1.3. Strategy

    27.2.1.4. Financial Performance

    27.2.2. Mylan NV

    27.2.2.1. Overview

    27.2.2.2. Products and Services

    27.2.2.3. Strategy

    27.2.2.4. Financial Performance

    27.2.3. Sandoz International GmbH

    27.2.3.1. Overview

    27.2.3.2. Products and Services

    27.2.3.3. Strategy

    27.2.3.4. Financial Performance

    27.2.4. Hospira (Pfizer Inc.)

    27.2.4.1. Overview

    27.2.4.2. Products and Services

    27.2.4.3. Strategy

    27.2.4.4. Financial Performance

    27.2.5. Sun Pharmaceutical

    27.2.5.1. Overview

    27.2.5.2. Products and Services

    27.2.5.3. Strategy

    27.2.5.4. Financial Performance

    28. Generic Pharmaceuticals Pipeline Analysis

    29. Key Mergers And Acquisitions In The Generic Pharmaceuticals Market

    30. Generic Pharmaceuticals Market Future Outlook and Potential Analysis

    31. Appendix

    31.1. Abbreviations

    31.2. Currencies

    31.3. Research Inquiries

    31.4. The Business Research Company

    31.5. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Table 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Table 3: Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 4: Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 5: Global Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 6: Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 7: Global Generic Pharmaceuticals Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 8: Global Generic Pharmaceuticals Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 9: Asia-Pacific, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 10: Asia-Pacific, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 11: China, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 12: China, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 13: India, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 14: India, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 15: Japan, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 16: Japan, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 17: Australia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 18: Australia, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 19: Indonesia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 20: Indonesia, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 21: South Korea, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 22: South Korea, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 23: Western Europe, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 24: Western Europe, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 25: UK, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 26: UK, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 27: Germany, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 28: Germany, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 29: France, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 30: France, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 31: Eastern Europe, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 32: Eastern Europe, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 33: Russia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 34: Russia, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 35: North America, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 36: North America, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 37: USA, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 38: USA, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 39: South America, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 40: South America, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 41: Brazil, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 42: Brazil, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 43: Middle East, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 44: Middle East, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 45: Africa, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 46: Africa, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Table 47: Teva Pharmaceuticals Financial Performance
  • Table 48: Mylan NV Financial Performance
  • Table 49: Sandoz International GmbH Financial Performance
  • Table 50: Hospira (Pfizer Inc.) Financial Performance
  • Table 51: Sun Pharmaceutical Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2015-2020, $ Billion
  • Figure 2: Global Forecast Market Growth, 2020-2025F, 2030F, $ Billion
  • Figure 3: Global Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 4: Global Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 5: Global Generic Pharmaceuticals Market, Segmentation By Type, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 6: Global Generic Pharmaceuticals Market, Segmentation By Drug Delivery, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 7: Global Generic Pharmaceuticals Market, Split By Region, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 8: Global Generic Pharmaceuticals Market, Split By Country, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 9: Asia-Pacific, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 10: Asia-Pacific, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 11: China, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 12: China, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 13: India, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 14: India, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 15: Japan, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 16: Japan, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 17: Australia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 18: Australia, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 19: Indonesia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 20: Indonesia, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 21: South Korea, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 22: South Korea, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 23: Western Europe, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 24: Western Europe, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 25: UK, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 26: UK, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 27: Germany, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 28: Germany, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 29: France, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 30: France, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 31: Eastern Europe, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 32: Eastern Europe, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 33: Russia, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 34: Russia, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 35: North America, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 36: North America, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 37: USA, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 38: USA, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 39: South America, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 40: South America, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 41: Brazil, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 42: Brazil, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 43: Middle East, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 44: Middle East, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 45: Africa, Generic Pharmaceuticals Market, Segmentation By Therapy, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 46: Africa, Generic Pharmaceuticals Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2020, 2020-2025F, 2030F, $ Billion
  • Figure 47: Teva Pharmaceuticals Financial Performance
  • Figure 48: Mylan NV Financial Performance
  • Figure 49: Sandoz International GmbH Financial Performance
  • Figure 50: Hospira (Pfizer Inc.) Financial Performance
  • Figure 51: Sun Pharmaceutical Financial Performance
Global Psoriasis Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Psoriatic Arthritis Treatment Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Regenerative Medicine For Cartilage Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Radiopharmaceuticals Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Remdesivir Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Research Antibodies and Reagents Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Rituximab Biosimilars Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Global Respiratory Diseases Drugs Market Report 2021 – Opportunities And Strategies, Market Forecast And Trends
Pharmaceutical API Manufacturing Global Market Report 2021 - By Therapy Area (Cardiovascular Disorders, Metabolic Disorders, Neurological Disorders, Oncology, Musculoskeletal Disorders, NSAIDs, Other Therapeutics Uses), By API Type (Chemical API, Biological API), By Drug Type (Innovative Drugs, Generic Prescription, Over-The-Counter (OTC) Drugs), COVID-19 Growth And Change
View Report
Pharmaceuticals Market - By Type (Pharmaceutical Drugs, Biologics), By Type Of Pharmaceutical Drugs (Cardiovascular Drugs, Dermatology Drugs, Gastrointestinal Drugs, Genito-Urinary Drugs, Hematology Drugs, Anti-Infective Drugs, Metabolic Disorder Drugs, Musculoskeletal Disorder Drugs, Central Nervous System Drugs, Oncology Drugs, Ophthalmology Drugs, Respiratory Diseases Drugs), By Type Of Biologics Drugs (Monoclonal Antibodies (MAbS), Therapeutic Proteins, Vaccines), And By Region, Opportunities And Strategies – Global Forecast To 2030
View Report
Antifungals Global Market Report 2021 - By Drug Type (Echinocandins, Azoles, Polyenes, Allylamines), By End Users (Hospitals & Clinics, Dermatology Clinics), By Route of Administration (Oral, Parenteral, Topical), By Therapeutic Indications (Aspergillosis, Dermatophytosis, Candidiasis), COVID-19 Impact and Recovery
View Report
Global Biologics Market - By Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), By Route Of Administration (Oral, Others (IV or IP)), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription Drugs, OTC Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2023
View Report
Global Biologics Market - By Type (Monoclonal Antibodies, Therapeutic Proteins, Vaccines), By Route Of Administration (Oral, Others (IV or IP)), By Drug Classification (Branded Drugs, Generic Drugs), By Mode Of Purchase (Prescription Drugs, OTC Drugs), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies – Global Forecast To 2023
View Report
Anemia And Other Blood Disorder Drugs Global Market Report 2021 - By Type (Iron Deficiency Anemia, Chronic Kidney Disease Anemia, Sickle Cell Anemia, Aplastic Anemia), By Distribution Channel (Hospitals Pharmacy, Online Pharmacy, Pharmacy), By Route of Administration (Oral, Injectable), By Anemia Type (Microcytic (Low MCV), Normocytic (Normal MCV), Macrocytic (High MCV)), COVID-19 Impact And Recovery
View Report
Pharmaceutical Drugs And Biologics Logistics Market - By Type Of Service (Cold Chain Logistics, Non-Cold Chain Logistics), By Mode Of Transport (Air Transportation, Ocean Transportation, Land Transportation), By Pharmaceutical Type (Pharmaceutical Drugs, Biologics), By Therapeutic Area (Metabolic Disorders Drugs, Anti-Infective Drugs, Central Nervous System Drugs, Respiratory Diseases Drugs, Cardiovascular Drugs, Musculoskeletal Disorders Drugs, Oncology Drugs, Hematology Drugs, Monoclonal Antibodies (MAbS), Genito-Urinary Drugs, Gastrointestinal Drugs, Therapeutic Proteins, Dermatology Drugs, Vaccines, Ophthalmology Drugs), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report
Oral Biologics And Biosimilars Market - By Therapeutic Mechanism (Tumor Necrosis Factor-Alpha Inhibitors, Lymphocyte Modulators, Interleukin Inhibitors, GPCR (insulin, growth hormone, parathyroid hormone) Modulators, Immunostimulants, Others), By Disease (Diabetes, Arthritis & Chron`s Disease, Cancer, Infectious Diseases, Other Autoimmune Diseases, Others Diseases), By Molecule Type (Vaccines, Proteins & Peptides, Monoclonal Antibodies, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), And By Region, Opportunities And Strategies - Global Forecast To 2030
View Report

Call Us

+1 3156230293

(Americas)

+44 2071930708

(Europe)

+91 8897263534

(Asia & Others)